Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. David Bates

General Internal Medicine · BWH

View

Dr. Kartik Goswami

General Internal Medicine · KFH - Santa Clara

View

Dr. Yilin (Gloria) Song

General Internal Medicine · Maryland General Hospital

View

Dr. Rachel Alexander

General Internal Medicine · Georgetown University

View

Dr. Irina Kryzhanovskaya

General Internal Medicine · UCSF

View

Dr. Mathew Alexander

General Internal Medicine · Johns Hopkins

View

Dr. Paul Wurtz

General Internal Medicine · USU

View

Dr. Rabih Geha

General Internal Medicine · UCSF

View

Dr. Paul Williams

General Internal Medicine · Penn State Hershey Medical Center

View

Dr. Natasha Steele

General Internal Medicine · Stanford

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    Impact of Myocardial Fibrosis and Female Sex on Life-Threatening Arrhythmias and Sudden Cardiac Death in Mitral Valve Prolapse.

    Aug 4, 2026DOI: 10.1161/circimaging.126.020017Journal ArticleAHA

    Written by: Amr DarwishDuc T NguyenThammarak SongsangjindaDanai KitkungvanMujtaba SaeedAkila BersaliFatima QamarMariya PotapenkoFareeha DadabhoyLionel TastetK Carlos El-TallawiGerald LawrieMiguel ValderrábanoFrancesca N DellingEdward A GravissRaymond J KimDipan J Shah

    Find these authors on Roon

    MS
    Dr. Mujtaba Saeed
    General Internal Medicine · AECOM

    Summary

    BACKGROUND: Mitral valve prolapse (MVP) is a common cardiac condition that is generally benign, yet a subset of affected patients develop malignant ventricular arrhythmias and sudden cardiac death. Female sex and myocardial fibrosis detected by late gadolinium enhancement on cardiovascular magnetic resonance imaging have been proposed as risk factors though their independent contributions to arrhythmic risk remain uncertain.METHODS: We conducted a prospective cohort study of 550 consecutive patients with MVP referred for cardiovascular magnetic resonance at a tertiary academic center between May 2008 and December 2021. Patients with potential confounders, including coronary artery disease, cardiomyopathy, infiltrative disease, or prior cardiac surgery, were excluded. The primary end point was a composite arrhythmic outcome comprising sudden cardiac death, aborted sudden cardiac arrest, and symptomatic sustained or inducible ventricular tachycardia or ventricular fibrillation leading to implantable cardioverter defibrillator placement or ventricular ablation at an MVP-related scar site.RESULTS: Among the 550 patients (median age, 62 [interquartile range, 52-71] years; 50% women), LGE was present in 210 (38%). Over a median follow-up of 4.4 years (interquartile range, 2.8-7.1; 2700 patient-years), 48 patients (8.7%) reached the primary end point. On univariable analysis, both female sex (hazard ratio, 3.33 [95% CI, 1.72-6.44]; P<0.001) and LGE presence (hazard ratio, 3.17 [95% CI, 1.74-5.77]; P<0.001) were significantly associated with arrhythmic events, and both remained independently associated on multivariable analysis. Women with LGE represented the highest-risk subgroup, with a 5-year event-free survival of 76.5%, compared with 98.5% in men without LGE (P<0.001).CONCLUSIONS: In a large prospective cardiovascular magnetic resonance cohort of patients with MVP, female sex and myocardial fibrosis were each independently associated with life-threatening arrhythmic events. Their combination identified a subgroup at particularly elevated risk, highlighting the importance of integrating sex-specific factors and myocardial tissue characterization into MVP risk stratification strategies.
    MSDr. Mujtaba Saeed

    Dr. Mujtaba Saeed

    Internal Medicine · General Internal Medicine
    Albert Einstein College of Medicine
    mujtaba